Citius Oncology, Inc. Common Stock
€0.76402
EUR
Last updated on --.
24h volume78.06K
24h highest0.76540 EUR
24h lowest0.69789 EUR
24h Price movement+3.30%
CTOR recent prices
24 Hours
+3.30%+€0.024424
30 days
-0.80%-€0.005934
60 days
+74.44%+€0.31562
90 days
-23.21%-€0.2236
Key data
Previous close0.73960 EUR
Market cap66.05M EUR
Volume78.06K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.39560 EUR
Net income (FY)-36.56M EUR
Revenue (FY)4.83M EUR
Last report dateMay 15, 2026
About Citius Oncology, Inc. Common Stock
HeadquartersCRANFORD
Listed onNasdaq
CTOR conversion tables
 |  |
|---|---|
| 0.5 CTOR | 0.38201 EUR |
| 1 CTOR | 0.76402 EUR |
| 5 CTOR | 3.820 EUR |
| 10 CTOR | 7.640 EUR |
| |
|---|---|
| 0.5 EUR | 0.65443 CTOR |
| 1 EUR | 1.308 CTOR |
| 5 EUR | 6.544 CTOR |
| 10 EUR | 13.08 CTOR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CTOR is trading at €0.76402, +3.30% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CTOR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CTOR is currently trading at €0.76402, +3.30% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CTOR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CTOR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CTOR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CTOR's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Citius Oncology, Inc. Common Stock's market cap is currently 66.05M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume78.06K
24h highest0.76540 EUR
24h lowest0.69789 EUR
24h Price movement+3.30%
Start trade with CTOR Perpetual
Sign up to trade